The global Ultomiris Drug Market is poised for significant expansion, with the market projected to grow from USD 5.2 billion in 2025 to USD 14.9 billion by 2033, registering a CAGR of 14.4% during the forecast period. The market is witnessing robust growth due to the increasing prevalence of rare blood disorders, expanding regulatory approvals, growing adoption...